ALPORT SYNDROME

Clinical trials for ALPORT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALPORT SYNDROME trials appear

Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 5 Terminated 1

Race to slow kidney failure in rare genetic disease

Disease control Terminated

This study tested whether a weekly injection called lademirsen could safely slow the decline of kidney function in adults with Alport syndrome, a genetic condition that damages the kidneys. It involved 43 participants who received either the drug or a placebo for nearly a year. T…

Matched conditions: ALPORT SYNDROME

Phase: PHASE2 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

ALPORT SYNDROME

Get alerted when new ALPORT SYNDROME trials appear

Race to slow kidney failure in rare genetic disease